Cargando…

The SARS-CoV-2 B.1.1.7 variant and increased clinical severity—the jury is out

Detalles Bibliográficos
Autores principales:	Giles, Benjamin, Meredith, Paul, Robson, Samuel, Smith, Gary, Chauhan, Anoop
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238445/ https://www.ncbi.nlm.nih.gov/pubmed/34197767 http://dx.doi.org/10.1016/S1473-3099(21)00356-X

Ejemplares similares

Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people
por: Brookman, Sarah, et al.
Publicado: (2021)

Structure-based evidence for the enhanced transmissibility of the dominant SARS-CoV-2 B.1.1.7 variant (Alpha)
por: Xia, Shuai, et al.
Publicado: (2021)

COVID-19 and liver transplantation: the jury is still out
por: Tavabie, Oliver D, et al.
Publicado: (2021)

SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity
por: Ramanathan, Muthukumar, et al.
Publicado: (2021)

COVID-19 and liver transplantation: the jury is still out – Authors' reply
por: Webb, Gwilym J, et al.
Publicado: (2021)

COVID-19, ACEI/ARBs, and Gastrointestinal Symptoms: The Jury Is Still Out on the Association
por: Parigi, Tommaso Lorenzo, et al.
Publicado: (2021)

Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
por: Abu-Raddad, Laith J., et al.
Publicado: (2021)

First detection of SARS-CoV-2 variant B.1.1.7 in Senegal
por: Padane, A., et al.
Publicado: (2021)

Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland
por: Chen, Chaoran, et al.
Publicado: (2021)

Tracking of SARS-CoV-2 Alpha variant (B.1.1.7) in Palestine
por: Nasereddin, Abedelmajeed, et al.
Publicado: (2022)

Influence of age on the spread of SARS-CoV-2 variant B.1.1.7
por: Dimeglio, Chloé, et al.
Publicado: (2021)

Impact of SARS-CoV-2 Alpha variant (B.1.1.7) on prisons, England
por: Vusirikala, Amoolya, et al.
Publicado: (2022)

Comparison of the Performance of the PanBio COVID-19 Antigen Test in SARS-CoV-2 B.1.1.7 (Alpha) Variants versus non-B.1.1.7 Variants
por: van Ogtrop, M. L., et al.
Publicado: (2021)

Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
por: Wang, Pengfei, et al.
Publicado: (2021)

Fluoride carcinogenesis: The jury is still out!
por: Bajpai, Jyoti
Publicado: (2013)

Triclocarban and Health: the Jury Is Still Out
por: Kennedy, Rebekah C., et al.
Publicado: (2016)

Multiorgan tropism of SARS-CoV-2 lineage B.1.1.7
por: Ondruschka, Benjamin, et al.
Publicado: (2021)

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
por: Supasa, Piyada, et al.
Publicado: (2021)

The first familial cluster of the B.1.1.7 variant of SARS-CoV-2 in the northeast of Italy
por: Lo Menzo, Sara, et al.
Publicado: (2021)

Monitoring differences between the SARS-CoV-2 B.1.1.7 variant and other lineages
por: Jewell, Britta L
Publicado: (2021)

Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States
por: Alpert, Tara, et al.
Publicado: (2021)

Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2
por: Zhang, Jingsong, et al.
Publicado: (2021)

SARS-CoV-2 B.1.1.7 Variant Infection in Malayan Tigers, Virginia, USA
por: Mitchell, Patrick K., et al.
Publicado: (2021)

Introduction and transmission of SARS-CoV-2 lineage B.1.1.7, Alpha variant, in Denmark
por: Michaelsen, Thomas Y., et al.
Publicado: (2022)

The Alpha Variant (B.1.1.7) of SARS-CoV-2 Failed to Become Dominant in Mexico
por: Zárate, Selene, et al.
Publicado: (2022)

Idiopathic Intracranial Hypertension Associated with SARS-CoV-2 B.1.1.7 Variant of Concern
por: Khalid, Muhammad Faran, et al.
Publicado: (2021)

Genome sequencing of SARS-CoV-2 reveals the prevalence of variant B 1.1.7 in Egypt
por: Seadawy, Mohamed G., et al.
Publicado: (2022)

The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant
por: Hodgson, David, et al.
Publicado: (2021)

Immune transcriptomes from hospitalized patients infected with the SARS-CoV-2 variants B.1.1.7 and B.1.1.7 carrying the E484K escape mutation
por: Lee, Hye Kyung, et al.
Publicado: (2021)

Zika mosquito vectors: the jury is still out
por: Leal, Walter S.
Publicado: (2016)

Reply to “Triclocarban and Health: the Jury Is Still Out”
por: Pischel, Lauren, et al.
Publicado: (2016)

Bacteria may be in the liver, but the jury is still out
por: Broderick, Nichole A., et al.
Publicado: (2022)

Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study
por: Graham, Mark S, et al.
Publicado: (2021)

Early introductions and community transmission of SARS-CoV-2 variant B.1.1.7 in the United States
por: Alpert, Tara, et al.
Publicado: (2021)

Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis
por: Nyberg, Tommy, et al.
Publicado: (2021)

Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant
por: Thorne, Lucy G, et al.
Publicado: (2021)

Proliferation of SARS-CoV-2 B.1.1.7 Variant in Pakistan-A Short Surveillance Account
por: Umair, Massab, et al.
Publicado: (2021)

First Detection of SARS-CoV-2 B.1.1.7 Variant of Concern in an Asymptomatic Dog in Spain
por: Barroso-Arévalo, Sandra, et al.
Publicado: (2021)

SARS-CoV-2 B.1.1.7 Decline Is Not Driven by the Introduction of a More Successful Variant
por: Rodríguez-Grande, Cristina, et al.
Publicado: (2021)

The incubation period of the SARS-CoV-2 B1.1.7 variant is shorter than that of other strains
por: Homma, Yoshito, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t8n2m3u36bl7ijnv699gr9vp07